Background: Portal vein thrombosis (PVT) is increasingly frequently being diagnosed, but systematic descriptions of the natural history and clinical handling of the condition are sparse.

Although we found portal venous invasion to be the only significant independent risk factor among those evaluated, it may have limited clinical utility as a predictor. This study had several ...

Hepatocellular carcinoma (HCC) is one of most prevalent cancer and is a serious healthcare issue worldwide. Portal vein tumor thrombus (PVTT) is a frequent complication and remains as the blockage in ...

Prognostic implication of body composition changes in patients with borderline resectable/locally advanced pancreatic adenocarcinoma (PDAC) treated with mFOLFIRINOX. Comparison of hospital outcomes ...

School of Pharmacy, Shandong New Drug Loading & Release Technology and Preparation Engineering Laboratory, Binzhou Medical University, 346 Guanhai Road, Yantai 264003, P. R. China ...

卡博替尼（ Cabozantinib）是一种多激酶抑制剂（MKI），在美国获批用于晚期 HCC 后线治疗。近日，一则发表在 Clin J Gastroenterol 的病例分析描述了一例接受多种方案治疗后进展，而接受卡博替尼单药 6 ...

门静脉癌栓（portal vein tumor thrombus，PVTT）是肝细胞癌（hepatocellular carcinoma，HCC）最常见的血管侵犯形式。HCC 患者合并 PVTT 的发生率为 ...

Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCCAmezalpat builds momentum with both ...

Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.78% of subjects maintained a ...

The time has finally come: PlayStation Portal stock levels have leveled out in both the US and UK at all major retailers. We've been tracking the stock levels of the Portal particularly closely ...

With news from the transfer portal being important in the offseason, the retaining of an All-American player may just be the biggest roster news ahead of the 2025 campaign.